Every parliamentary written question tabled by Alicia Kearns this session, with the full answer and department. Back to the MP page.
Showing 21–40 of 403 · this parliament
What assessment he has made of the potential implications for his policies of the decision by the Australian Department of Defence to migrate its systems out of Global Switch data centres following the 2016 acquisition; and what steps his Department took to assess whether equivalent risks existed in the United Kingdom.
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
Whether any MoD data was stored in or transited through Global Switch data centres in London between December 2016 and December 2017.
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
Commonwealth and Development Affairs, if she will set out whether the Prime Minister and any Number 10 special adviser reviewed the shortlist for the incoming special envoy for hostage affairs; and if Number 10 has selected a candidate to take up the position of special envoy for hostage affairs.
I refer the Hon Member to the answer she was provided on 15 January 2025 in response to Question 22098.
When the Prime Minister was made aware that Peter Mandelson had failed his security vetting.
I refer the Hon Member to the Statement made by the Prime Minister on Security Vetting on the 20 April 2026, Official Report, Column 23-26.
Commonwealth and Development Affairs, whether Peter Mandelson's business and personal relationships with (a) individuals, (b) organisations and (c) government of the People's Republic of China were cited as reasons for his failed vetting.
I refer the Hon Member to the Prime Minister's statement to the House on 20 April and his answers to the questions raised in response.
Commonwealth and Development Affairs, how many currently serving Ambassadors have been appointed despite failing their security vetting.
Subject to the normal vetting process, all Heads of Mission are required to have Developed Vetting security clearance.
Commonwealth and Development Affairs, what information she held on the role of her Department in the vetting process for Lord Mandelson when she sent her letter to the Foreign Affairs Committee of 16 September 2025.
I refer the Hon Member to the Prime Minister's statement to the House on 20 April and his answers to the questions raised in response, and to the Foreign Secretary's letter to the Foreign Affairs Committee on 18 April, which is available on the Committee's website.
On what date the Cabinet was informed that (a) Peter Mandelson had failed his security vetting and (b) the Foreign, Commonwealth and Development Office had overruled the vetting failure.
I refer the Hon Member to the statement made by the Prime Minister on 20 April, and his answers to the questions raised in response, including his commitment that the Government would continue to comply with the instructions of Parliament in the Humble Address of 4 February.
Innovation and Technology, what costs were incurred for upgrading the Facility for Airborne Atmospheric Measurements (FAAM) Airborne Laboratory before its funding was ceased.
It has not proved possible to respond to the hon. Member in the time available before Prorogation.
What steps his Department is taking to mandate endometriosis and menstrual health training across GP and medical education in England.
The Government acknowledges the importance of ensuring healthcare professionals are adequately trained and educated on women’s health conditions, including endometriosis, and we have taken action to address this.The standard of undergraduate medical training is the responsibility of the General Medical Council (GMC), the independent regulator of the medical profession, which set the outcomes and standards expected at undergraduate level. Medical schools are responsible for their curricula. The delivery of these undergraduate curricula must meet the standards set by the GMC, who then monitor and check to make sure that these standards are maintained.The curriculum for specialty training is set by individual royal colleges and faculties. The GMC approves curricula and assessment systems for each training programme. Curricula emphasise the skills and approaches that a doctor must develop to ensure accurate and timely diagnoses and treatment plans for their patients.The Royal College of General Practitioners (RCGP) is responsible for publishing the postgraduate curriculum for general practitioners (GPs) and ensuring it remains up to date. The RCGP curriculum covers endometriosis as part of its gynaecology and breast health module.GPs are responsible for ensuring their own clinical knowledge remains up-to-date and for identifying learning needs as part of their continuing professional development. The RCGP has worked with partners, including Endometriosis UK, to develop educational resources relating to endometriosis to support GPs and other healthcare professionals to deliver the best possible care for women, based on the latest evidence.
What proportion of DVLA medical licence applications are processed digitally rather than by post.
In 2025/26, the DVLA received 1,003,453 driving licence applications, renewals and notifications where a medical condition needed to be investigated before a licence could be issued. Of these, 15 per cent were made via the DVLA’s online service. Until the end of March 2026, only a limited number of single medical conditions could be notified via the online DVLA’s Fitness to Drive Service. These included diabetes, Parkinsons, epilepsy, stroke, visual impairments or heart conditions. Notifications or renewals of all other medical conditions required applications to be submitted by post. However, the DVLA’s new online medical services portal was launched on 31 March 2026 and most customers can now notify or renew online through the DVLA’s driver and vehicles account. Driving licence applications where a medical condition(s) must be investigated before a licence can be issued can take longer as the DVLA is often reliant on information from third parties, including medical professionals, before a licence can be issued. The information requested about the average processing time for licence renewals where the applicant’s condition has been clinically stable for two or more consecutive years is not available as the DVLA is not required to hold information about periods of clinical stability. In 2025/26, the average processing time for all driving licence applications where a medical condition needed to be investigated was 56.66 working days.
What safeguards will be in place to prevent School Attendance Orders being issued to children who were removed from school due to documented harm to their mental health or wellbeing, including those with SEND needs.
Local authorities have existing duties to assess whether children not in school are receiving a suitable education. The department expects authorities to recruit candidates that can fulfil these statutory duties.The department will provide statutory guidance (which will be publicly consulted on), a training package, and additional funding to local authorities to support them to carry out the new duties created by the Children’s Wellbeing and Schools Bill. We will engage with relevant stakeholders on the guidance and materials to be included in the training package, such as in relation to home visits and children with special educational needs.The school attendance order (SAO) process is an existing process. SAOs must only be issued when a child is not receiving a suitable education, and it would be expedient for them to attend school. The Bill introduces a new power for local authorities to issue a SAO if it would be in the child’s best interests to attend school where the child is home educated and is on a child protection plan or has been in the previous five years or is subject to a Section 47 child protection enquiry. As part of the SAO process, the local authority should consider all relevant information it is aware of, which could include information about the child’s mental health, wellbeing or special educational needs.
What the average processing time is for DVLA medical licence renewals where the applicant's condition has been clinically stable for two or more consecutive years.
In 2025/26, the DVLA received 1,003,453 driving licence applications, renewals and notifications where a medical condition needed to be investigated before a licence could be issued. Of these, 15 per cent were made via the DVLA’s online service. Until the end of March 2026, only a limited number of single medical conditions could be notified via the online DVLA’s Fitness to Drive Service. These included diabetes, Parkinsons, epilepsy, stroke, visual impairments or heart conditions. Notifications or renewals of all other medical conditions required applications to be submitted by post. However, the DVLA’s new online medical services portal was launched on 31 March 2026 and most customers can now notify or renew online through the DVLA’s driver and vehicles account. Driving licence applications where a medical condition(s) must be investigated before a licence can be issued can take longer as the DVLA is often reliant on information from third parties, including medical professionals, before a licence can be issued. The information requested about the average processing time for licence renewals where the applicant’s condition has been clinically stable for two or more consecutive years is not available as the DVLA is not required to hold information about periods of clinical stability. In 2025/26, the average processing time for all driving licence applications where a medical condition needed to be investigated was 56.66 working days.
What guidance her Department will issue to local authorities on the level of weight to be given to a family's refusal of a home visit when assessing the suitability of home education under the Children's Wellbeing and Schools Bill.
Local authorities have existing duties to assess whether children not in school are receiving a suitable education. The department expects authorities to recruit candidates that can fulfil these statutory duties.The department will provide statutory guidance (which will be publicly consulted on), a training package, and additional funding to local authorities to support them to carry out the new duties created by the Children’s Wellbeing and Schools Bill. We will engage with relevant stakeholders on the guidance and materials to be included in the training package, such as in relation to home visits and children with special educational needs.The school attendance order (SAO) process is an existing process. SAOs must only be issued when a child is not receiving a suitable education, and it would be expedient for them to attend school. The Bill introduces a new power for local authorities to issue a SAO if it would be in the child’s best interests to attend school where the child is home educated and is on a child protection plan or has been in the previous five years or is subject to a Section 47 child protection enquiry. As part of the SAO process, the local authority should consider all relevant information it is aware of, which could include information about the child’s mental health, wellbeing or special educational needs.
What minimum qualifications or SEND-specific training local authority assessors will be required to hold before conducting home education suitability assessments under the Children's Wellbeing and Schools Bill.
Local authorities have existing duties to assess whether children not in school are receiving a suitable education. The department expects authorities to recruit candidates that can fulfil these statutory duties.The department will provide statutory guidance (which will be publicly consulted on), a training package, and additional funding to local authorities to support them to carry out the new duties created by the Children’s Wellbeing and Schools Bill. We will engage with relevant stakeholders on the guidance and materials to be included in the training package, such as in relation to home visits and children with special educational needs.The school attendance order (SAO) process is an existing process. SAOs must only be issued when a child is not receiving a suitable education, and it would be expedient for them to attend school. The Bill introduces a new power for local authorities to issue a SAO if it would be in the child’s best interests to attend school where the child is home educated and is on a child protection plan or has been in the previous five years or is subject to a Section 47 child protection enquiry. As part of the SAO process, the local authority should consider all relevant information it is aware of, which could include information about the child’s mental health, wellbeing or special educational needs.
Innovation and Technology, what assessment was made of the potential impact on UK atmospheric science capability before the decision to cease funding for the Facility for Airborne Atmospheric Measurements (FAAM) Airborne Laboratory.
I refer the hon. Member to the answers I gave on 26 March 2026 to Question UIN 122902, on 14 April 2026 to Question UIN 124177, and on 16 April 2026 to Question UIN 123983.
What contingency plans are in place if the supply of blood pressure medication is disrupted due to the war in Iran.
The Department is closely monitoring the Middle East conflict to assess any potential impact on United Kingdom medical supply chains through disruptions to manufacturing and logistics.We have limited direct exposure to the Middle East for medical products, and we maintain well‑established contingency arrangements to manage medicine and medical device supply disruptions where these occur. These can include coordination of mutual aid, work to identify alternative products, alternative clinical practices, regulatory easements, and/or use of the Express Freight Service which can provide bespoke global logistics services in the event of critical supply disruption.The Department is not aware of supply issues impacting codeine and co-codamol as a result of the conflict. The Department is aware of supply constraints affecting co-codamol 30 milligram/500 milligram tablets, which pre-date the conflict and which are due to manufacturing issues. These are in limited supply until early July 2026. We have engaged with National Health Service specialist clinicians and issued comprehensive guidance on how to manage patients during this time and advise on available alternative preparations.
What assessment he has made of the potential impact of the war in Iran on the current level of codeine and co-codamol.
The Department is closely monitoring the Middle East conflict to assess any potential impact on United Kingdom medical supply chains through disruptions to manufacturing and logistics.We have limited direct exposure to the Middle East for medical products, and we maintain well‑established contingency arrangements to manage medicine and medical device supply disruptions where these occur. These can include coordination of mutual aid, work to identify alternative products, alternative clinical practices, regulatory easements, and/or use of the Express Freight Service which can provide bespoke global logistics services in the event of critical supply disruption.The Department is not aware of supply issues impacting codeine and co-codamol as a result of the conflict. The Department is aware of supply constraints affecting co-codamol 30 milligram/500 milligram tablets, which pre-date the conflict and which are due to manufacturing issues. These are in limited supply until early July 2026. We have engaged with National Health Service specialist clinicians and issued comprehensive guidance on how to manage patients during this time and advise on available alternative preparations.
What contingency plans are in place if the supply of intravenous bags, syringes and gloves are disrupted due to the war in Iran.
The Department is closely monitoring the Middle East conflict to assess any potential impact on United Kingdom medical supply chains through disruptions to manufacturing and logistics.We have limited direct exposure to the Middle East for medical products, and we maintain well‑established contingency arrangements to manage medicine and medical device supply disruptions where these occur. These can include coordination of mutual aid, work to identify alternative products, alternative clinical practices, regulatory easements, and/or use of the Express Freight Service which can provide bespoke global logistics services in the event of critical supply disruption.The Department is not aware of supply issues impacting codeine and co-codamol as a result of the conflict. The Department is aware of supply constraints affecting co-codamol 30 milligram/500 milligram tablets, which pre-date the conflict and which are due to manufacturing issues. These are in limited supply until early July 2026. We have engaged with National Health Service specialist clinicians and issued comprehensive guidance on how to manage patients during this time and advise on available alternative preparations.
What assessment her Department has made of the potential impact of the war in Iran on medicine supply chains.
The Department is closely monitoring the Middle East conflict to assess any potential impact on United Kingdom medical supply chains through disruptions to manufacturing and logistics.We have limited direct exposure to the Middle East for medical products, and we maintain well‑established contingency arrangements to manage medicine and medical device supply disruptions where these occur. These can include coordination of mutual aid, work to identify alternative products, alternative clinical practices, regulatory easements, and/or use of the Express Freight Service which can provide bespoke global logistics services in the event of critical supply disruption.The Department is not aware of supply issues impacting codeine and co-codamol as a result of the conflict. The Department is aware of supply constraints affecting co-codamol 30 milligram/500 milligram tablets, which pre-date the conflict and which are due to manufacturing issues. These are in limited supply until early July 2026. We have engaged with National Health Service specialist clinicians and issued comprehensive guidance on how to manage patients during this time and advise on available alternative preparations.